Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance

被引:88
作者
Chou, SW
Lurain, NS
Weinberg, A
Cai, GY
Sharma, PL
Crumpacker, CS
机构
[1] Vet Adm Med Ctr, Infect Dis Sect P3ID, Portland, OR 97201 USA
[2] Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
[3] Univ Colorado, Hlth Sci Ctr, Denver, CO USA
[4] Beth Israel Deaconess Med Ctr, Boston, MA USA
关键词
D O I
10.1128/AAC.43.6.1500
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The polymerase (pol) coding sequence was determined for 40 independent clinical cytomegalovirus isolates sensitive to ganciclovir and foscarnet. Sequence alignments showed >98% interstrain homology and amino acid variation in only 4% of the 1,237 codons, Almost all variation occurred outside of conserved functional domains where resistance mutations have been identified.
引用
收藏
页码:1500 / 1502
页数:3
相关论文
共 14 条
[1]   The human cytomegalovirus genes and proteins required for DNA synthesis [J].
Anders, DG ;
McCue, LA .
INTERVIROLOGY, 1996, 39 (5-6) :378-388
[2]   Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS [J].
Baldanti, F ;
Underwood, MR ;
Stanat, SC ;
Biron, KK ;
Chou, SW ;
Sarasini, A ;
Silini, E ;
Gerna, G .
JOURNAL OF VIROLOGY, 1996, 70 (03) :1390-1395
[3]   Mutation in region III of the DNA polymerase gene conferring foscarnet resistance in cytomegalovirus isolates from 3 subjects receiving prolonged antiviral therapy [J].
Chou, SW ;
Marousek, G ;
Parenti, DM ;
Gordon, SM ;
La Voy, AG ;
Ross, JG ;
Miner, RC ;
Drew, WL .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (02) :526-530
[4]   ANALYSIS OF INTERSTRAIN VARIATION IN CYTOMEGALOVIRUS GLYCOPROTEIN-B SEQUENCES ENCODING NEUTRALIZATION-RELATED EPITOPES [J].
CHOU, SW ;
DENNISON, KM .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (06) :1229-1234
[5]   FREQUENCY OF UL97 PHOSPHOTRANSFERASE MUTATIONS RELATED TO GANCICLOVIR RESISTANCE IN CLINICAL CYTOMEGALOVIRUS ISOLATES [J].
CHOU, SW ;
GUENTZEL, S ;
MICHELS, KR ;
MINER, RC ;
DREW, WL .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (01) :239-242
[6]   Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease [J].
Chou, SW ;
Marousek, G ;
Guentzel, S ;
Follansbee, SE ;
Poscher, ME ;
Lalezari, JP ;
Miner, RC ;
Drew, WL .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (03) :786-789
[7]   A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture [J].
Cihlar, T ;
Fuller, MD ;
Mulato, AS ;
Cherrington, JM .
VIROLOGY, 1998, 248 (02) :382-393
[8]   Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments [J].
Cihlar, T ;
Fuller, MD ;
Cherrington, JM .
JOURNAL OF VIROLOGY, 1998, 72 (07) :5927-5936
[9]  
CRUMPACKER CS, 1996, J ACQUIRED IMMUNE S1, V12, pS1
[10]  
Drew W L, 1993, Clin Diagn Virol, V1, P179